Also known as: Stenabolic
SR9009, also known as Stenabolic, is a synthetic compound categorized under fat loss and metabolic peptides. It functions primarily as a Rev-ErbA agonist, influencing metabolic processes in the body. This peptide has gained attention in research for its potential effects on metabolism, endurance, and fat loss.
SR9009 operates by activating the Rev-ErbA protein, which plays a crucial role in regulating circadian rhythms and metabolic functions. By binding to this protein, SR9009 can enhance the body’s ability to burn fat and improve overall energy expenditure. This mechanism is thought to influence various metabolic pathways, including lipid metabolism and glucose homeostasis.
The activation of Rev-ErbA leads to increased mitochondrial biogenesis and improved muscle performance, contributing to enhanced endurance and fat oxidation.
SR9009 is a peptide with significant implications in metabolic regulation and fat loss. Its role as a Rev-ErbA agonist positions it as a valuable subject for research in enhancing endurance and metabolic health.
Last updated: Feb 25, 2026